115 related articles for article (PubMed ID: 38700461)
1. Use of medical therapy and risk of clinical events according to frailty in heart failure patients - A real-life cohort study.
Zahir Anjum D; Strange JE; Fosbøl E; Garred CH; Elmegaard M; Andersson C; Jhund PS; McMurray JJV; Petrie MC; Kober L; Schou M
Eur J Heart Fail; 2024 May; ():. PubMed ID: 38700461
[TBL] [Abstract][Full Text] [Related]
2. Frailty Status Modifies the Efficacy of Exercise Training Among Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the HF-ACTION Trial.
Pandey A; Segar MW; Singh S; Reeves GR; O'Connor C; Piña I; Whellan D; Kraus WE; Mentz RJ; Kitzman DW
Circulation; 2022 Jul; 146(2):80-90. PubMed ID: 35616018
[TBL] [Abstract][Full Text] [Related]
3. Initiation of Medical Therapy for Heart Failure Patients According to Kidney Function: A Danish Nationwide Study.
Zahir Anjum D; Strange JE; Fosbøl E; Garred CH; Malik ME; Andersson C; Jhund PS; McMurray JJV; Petrie MC; Kober L; Schou M
Clin Epidemiol; 2023; 15():855-866. PubMed ID: 37489222
[TBL] [Abstract][Full Text] [Related]
4. Body mass index, frailty, and outcomes in heart failure with preserved ejection fraction.
Li W; Wang Z; Hua C; Zhang H; Liu X; Zheng S; Lv Q; Jiang C; Dong J; Ma C; Du X
ESC Heart Fail; 2024 Apr; 11(2):709-718. PubMed ID: 38131256
[TBL] [Abstract][Full Text] [Related]
5. Frailty and uptake of angiotensin receptor neprilysin inhibitor for heart failure with reduced ejection fraction.
Lee YC; Lin JK; Ko D; Cheng S; Patorno E; Glynn RJ; Tsacogianis T; Kim DH
J Am Geriatr Soc; 2023 Oct; 71(10):3110-3121. PubMed ID: 37345734
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR-Preserved.
Coats AJS; Butler J; Tsutsui H; Doehner W; Filippatos G; Ferreira JP; Böhm M; Chopra VK; Verma S; Nordaby M; Iwata T; Nitta D; Ponikowski P; Zannad F; Packer M; Anker SD
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):412-424. PubMed ID: 38158636
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and Prognostic Significance of Frailty in Asian Patients With Heart Failure: Insights From ASIAN-HF.
Aung T; Qin Y; Tay WT; Binte Salahudin Bamadhaj NS; Chandramouli C; Ouwerkerk W; Tromp J; Anand I; Richards AM; Hung CL; Teramoto K; Katherine Teng TH; Lam CSP
JACC Asia; 2021 Dec; 1(3):303-313. PubMed ID: 36341220
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure.
Vidán MT; Blaya-Novakova V; Sánchez E; Ortiz J; Serra-Rexach JA; Bueno H
Eur J Heart Fail; 2016 Jul; 18(7):869-75. PubMed ID: 27072307
[TBL] [Abstract][Full Text] [Related]
9. Benefits of heart failure-specific pharmacotherapy in frail hospitalised patients: a cross-sectional study.
Sharma Y; Horwood C; Hakendorf P; Thompson C
BMJ Open; 2022 Sep; 12(9):e059905. PubMed ID: 36123054
[TBL] [Abstract][Full Text] [Related]
10. The burden of frailty in heart failure: Prevalence, impacts on clinical outcomes and the role of heart failure medications.
Lai HY; Huang ST; Anker SD; von Haehling S; Akishita M; Arai H; Chen LK; Hsiao FY
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):660-670. PubMed ID: 38291000
[TBL] [Abstract][Full Text] [Related]
11. Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial.
Khan MS; Segar MW; Usman MS; Singh S; Greene SJ; Fonarow GC; Anker SD; Felker GM; Januzzi JL; Butler J; Pandey A
JACC Heart Fail; 2022 Apr; 10(4):266-275. PubMed ID: 35361446
[TBL] [Abstract][Full Text] [Related]
12. Developing a Parsimonious Frailty Index for Older, Multimorbid Adults With Heart Failure Using Machine Learning.
Razjouyan J; Horstman MJ; Orkaby AR; Virani SS; Intrator O; Goyal P; Amos CI; Naik AD
Am J Cardiol; 2023 Mar; 190():75-81. PubMed ID: 36566620
[TBL] [Abstract][Full Text] [Related]
13. Frailty and outcomes in heart failure patients from high-, middle-, and low-income countries.
Leong DP; Joseph P; McMurray JJV; Rouleau J; Maggioni AP; Lanas F; Sharma SK; Núñez J; Mohan B; Celik A; Abdullakutty J; Ogah OS; Mielniczuk LM; Balasubramanian K; McCready T; Grinvalds A; Yusuf S
Eur Heart J; 2023 Nov; 44(42):4435-4444. PubMed ID: 37639487
[TBL] [Abstract][Full Text] [Related]
14. Physical Frailty and Use of Guideline-Recommended Drugs in Patients With Heart Failure and Reduced Ejection Fraction.
Kondo T; Adachi T; Kobayashi K; Okumura T; Izawa H; Murohara T; McMurray JJV; Yamada S
J Am Heart Assoc; 2023 Jun; 12(12):e026844. PubMed ID: 37301739
[TBL] [Abstract][Full Text] [Related]
15. The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE.
Dewan P; Jackson A; Jhund PS; Shen L; Ferreira JP; Petrie MC; Abraham WT; Desai AS; Dickstein K; Køber L; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; McMurray JJV
Eur J Heart Fail; 2020 Nov; 22(11):2123-2133. PubMed ID: 32353205
[TBL] [Abstract][Full Text] [Related]
16. Effect of frailty on treatment, hospitalisation and death in patients with chronic heart failure.
Sze S; Pellicori P; Zhang J; Weston J; Squire IB; Clark AL
Clin Res Cardiol; 2021 Aug; 110(8):1249-1258. PubMed ID: 33399955
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry.
Greene SJ; Butler J; Hellkamp AS; Spertus JA; Vaduganathan M; Devore AD; Albert NM; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC
J Card Fail; 2022 Mar; 28(3):370-384. PubMed ID: 34793971
[TBL] [Abstract][Full Text] [Related]
18. Frailty Assessment in Advanced Heart Failure.
Madan SA; Fida N; Barman P; Sims D; Shin J; Verghese J; Piña I; Jorde U; Patel SR
J Card Fail; 2016 Oct; 22(10):840-4. PubMed ID: 26883168
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of frailty based on a comprehensive frailty assessment in patients with heart failure.
Hamada T; Kubo T; Kawai K; Nakaoka Y; Yabe T; Furuno T; Yamada E; Kitaoka H;
ESC Heart Fail; 2024 Mar; ():. PubMed ID: 38549188
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
Ehteshami-Afshar S; Mooney L; Dewan P; Desai AS; Lang NN; Lefkowitz MP; Petrie MC; Rizkala AR; Rouleau JL; Solomon SD; Swedberg K; Shi VC; Zile MR; Packer M; McMurray JJV; Jhund PS; Hawkins NM
J Am Heart Assoc; 2021 Feb; 10(4):e019238. PubMed ID: 33522249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
